{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:18:52Z","timestamp":1785442732014,"version":"3.56.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/bf03027426","type":"journal-article","created":{"date-parts":[[2009,1,17]],"date-time":"2009-01-17T00:17:45Z","timestamp":1232151465000},"page":"171-174","source":"Crossref","is-referenced-by-count":17,"title":["Prognostic value of FDG-PET in patients with ovarian carcinoma following surgical treatment"],"prefix":"10.1007","volume":"20","author":[{"given":"Atsushi","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Uki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Maruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Oriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Izuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03027426_CR1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s003300051000","volume":"10","author":"RA Kubik-Huch","year":"2000","unstructured":"Kubik-Huch RA, Dorffler W, von Schulthess GK, Marincek B, Kochli OR, Seifert B, et al. Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.Eur Radiol 2000; 10:761\u2013767.","journal-title":"Eur Radiol"},{"key":"BF03027426_CR2","first-page":"3691","volume":"21","author":"RF Yen","year":"2001","unstructured":"Yen RF, Sun SS, Shen YY, Changlai SP, Kao A. Whole body positron emission tomography with18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.Anticancer Res 2001; 21:3691\u20133694.","journal-title":"Anticancer Res"},{"key":"BF03027426_CR3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2214\/ajr.176.6.1761449","volume":"176","author":"Y Nakamoto","year":"2001","unstructured":"Nakamoto Y, Saga T, Ishimori T, Mamede M, Togashi K, Higuchi T, et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer.AJR Am J Roentgenol 2001; 176:1449\u20131454.","journal-title":"AJR Am J Roentgenol"},{"key":"BF03027426_CR4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00259-001-0750-9","volume":"29","author":"T Torizuka","year":"2002","unstructured":"Torizuka T, Nobezawa S, Kanno T, Futatsubashi M, Yoshikawa E, Okada H, et al. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose.Eur J Nucl Med Mol Imaging 2002; 29:797\u2013803.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF03027426_CR5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/gyno.2001.6386","volume":"83","author":"M Zimny","year":"2001","unstructured":"Zimny M, Siggelkow W, Schroder W, Nowak B, Biemann S, Rath W, et al. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer.Gynecol Oncol 2001; 83:310\u2013315.","journal-title":"Gynecol Oncol"},{"key":"BF03027426_CR6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00259-003-1367-y","volume":"31","author":"S Kim","year":"2004","unstructured":"Kim S, Chung JK, Kang SB, Kim MH, Jeong JM, Lee DS, et al. [18F] FDG PET as a substitute for second-look lapa-rotomy in patients with advanced ovarian carcinoma.Eur J Nucl Med Mol Imaging 2004; 31:196\u2013201.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"348","key":"BF03027426_CR7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(05)66133-8","volume":"20","author":"G Rustin","year":"1996;","unstructured":"Rustin G, Tuxen M. Use of CA-125 in follow-up of ovarian cancer.Lancet 1996; 20; 348:191\u2013192.","journal-title":"Lancet"},{"key":"BF03027426_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/030089168907500118","volume":"75","author":"F Zanaboni","year":"1989","unstructured":"Zanaboni F, Presti M, Scarfone G, Bolis G. CA-125 reliability in predicting ovarian cancer recurrence.Tumori 1989; 75:69\u201371.","journal-title":"Tumori"},{"key":"BF03027426_CR9","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1200\/JCO.2004.10.028","volume":"22","author":"B Gronlund","year":"2004","unstructured":"Gronlund B, Hogdall C, Hilden J, Engelholm SA, Hogdall EV, Hansen HH. Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?J Clin Oncol 2004; 22:4051\u20134058.","journal-title":"J Clin Oncol"},{"key":"BF03027426_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.1993.1076","volume":"49","author":"AP Makar","year":"1993","unstructured":"Makar AP, Kristensen GB, Bormer OP, Trope CG. Is serum CA-125 at the time of relapse a prognostic indicator for further survival prognosis in patients with ovarian cancer?Gynecol Oncol 1993; 49:3\u20137.","journal-title":"Gynecol Oncol"},{"key":"BF03027426_CR11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1525-1438.1997.00424.x","volume":"7","author":"A Gadducci","year":"1997","unstructured":"Gadducci A, Landoni F, Maggino T, Sartori E, Zola P, Ferdeghini M, et al. Serum CA-125 assay at the time of relapse has no prognostic relevance in patients undergoing chemotherapy for recurrent ovarian cancer: a multicenter Italian study.Int J Gynecol Cancer 1997; 7:78\u201383.","journal-title":"Int J Gynecol Cancer"},{"key":"BF03027426_CR12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF03027393","volume":"19","author":"N Khan","year":"2005","unstructured":"Khan N, Oriuchi N, Yoshizaki A, Kanuma T, Higuchi T, Endo K. Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer.Ann Nucl Med 2005; 19:137\u2013145.","journal-title":"Ann Nucl Med"},{"key":"BF03027426_CR13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/02841860151116420","volume":"40","author":"T Hogberg","year":"2001","unstructured":"Hogberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in ovarian cancer.Acta Oncol 2001; 40:340\u2013360.","journal-title":"Acta Oncol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03027426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03027426\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03027426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:33:05Z","timestamp":1558557185000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03027426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["BF03027426"],"URL":"https:\/\/doi.org\/10.1007\/bf03027426","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}